Immune Suppression and Response to Ipilimumab: Assessing Risk-to-Benefit Ratio

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio

Specimen extraction is one of the most challenging steps during minimally invasive procedures. Theoretically, any surgical specimens have to be considered potentially malignant and therefore they have to be removed without contamination of the operative field [1]. However, solid and large masses (e.g., uterine myomas) cannot be removed easily, from the small abdominal incisions used for minimal...

متن کامل

Assessing Response of High-Grade Gliomas to Immune Checkpoint Inhibitors.

BACKGROUND Immunotherapeutic agents, especially checkpoint inhibitors, have emerged as the mainstay of therapy for several solid and hematological malignancies. These therapies are under investigation for the treatment of high-grade gliomas and brain metastases. METHODS This article reviews the unique challenges encountered when evaluating changes on magnetic resonance imaging (MRI) of gliobl...

متن کامل

Managing immune-related adverse events to ipilimumab: a nurse's guide.

Ipilimumab is a U.S. Food and Drug Administration-approved novel T-cell potentiator that improves survival in metastatic melanoma. Ipilimumab blocks cytotoxic T-lymphocyte antigen-4, a negative regulator of the immune response, thus promoting T-cell activation and prolonging a patient's antitumor response. However, that action may produce a mechanism-related spectrum of immune-related adverse e...

متن کامل

Metastatic melanoma response to combination therapy with ipilimumab and vemurafenib.

Combination therapies for the treatment of metastatic melanoma are a matter of debate nowadays. We report on a stage IV metastatic melanoma patient with the BRAF V600 mutation and a large tumor burden initially treated with two cycles of ipilimumab. Due to dramatic disease progression, demonstrated on interim 18F-FDG PET/CT, vemurafenib was added in the patient's therapeutical scheme. After com...

متن کامل

iranian english learners’ perception and personality: a dual approach to investigating influential factors on willingness to communicate

abstract previous studies on willingness to communicate (wtc) have shown the influence of many individual or situational factors on students’ tendency to engage in classroom communication, in which wtc has been viewed either at the trait-level or situational level. however, due to the complexity of the notion of willingness to communicate, the present study suggests that these two strands are ...

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Clinical Oncology

سال: 2016

ISSN: 0732-183X,1527-7755

DOI: 10.1200/jco.2015.65.0028